Development of computerized alerts with management strategies for 25 serious drug-drug interactions

被引:10
|
作者
Murphy, John E. [1 ]
Malone, Daniel G. [1 ]
Olson, Bridget M. [2 ]
Grizzle, Amy J.
Armstrong, Edward P. [1 ]
Skrepnek, Grant I. [1 ]
机构
[1] Univ Arizona, Coll Pharm, Tucson, AZ 85721 USA
[2] Dymaxium Inc, San Diego, CA USA
关键词
Ambulatory care; Computers; Drug interactions; Quality assurance; QUESTIONNAIRE SURVEY; GENERAL-PRACTICE; PRIMARY-CARE; COMMUNITY;
D O I
10.2146/ajhp070046
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Purpose. The development of computerized alerts with management strategies for 25 drug-drug interactions (DDIs) is described. Summary. To ensure that clinicians, when confronted with any of 25 serious DDIs in the ambulatory care setting, can avoid these DDIs while treating patients with appropriate medications, management strategies were developed using a consensus approach. Several methods were used to ensure that the recommended alternatives were truly safe. Four well-stablished drug-interaction compendia were screened, and any potential alternative agent that was listed as having an interaction (moderate or serious in nature) was excluded from the list of alternative agents. Case reports, case series, and clinical studies that focused on the alternative combinations were reviewed to determine if the alternative posed interaction risks. If an interaction for the alternative combination had not been identified in the compendia or in the literature search, other potential mechanisms for drug interactions were explored such as alterations in absorption, distribution, metabolism, or excretion. Pharmacology and therapeutics textbooks and other drug information sources also served as resources. In general, the strategies included alternatives to both medications, changing dosage or increasing monitoring of one of the agents, situations where one of the medications had no alternative but alternatives were available for the other medication, and alternative methods of birth control. In some situations the two drugs were contraindicated, while in others the two drugs should be avoided if at all possible and alternatives used. Conclusion. Consensus-based management strategies for 25 serious DDIs were developed for inclusion in computerized alert messages.
引用
收藏
页码:38 / 44
页数:7
相关论文
共 50 条
  • [21] Drug-drug interactions
    Preskorn, SH
    JOURNAL OF CLINICAL PSYCHIATRY, 1996, 57 (05) : 223 - 225
  • [22] New strategies to address drug-drug interactions involving OATPs
    Poirier, Agnes
    Funk, Christoph
    Lave, Thierry
    Noe, Johannes
    CURRENT OPINION IN DRUG DISCOVERY & DEVELOPMENT, 2007, 10 (01) : 74 - 83
  • [23] Serious adverse drug reactions identified as Drug-Drug interactions by the French spontaneous reporting system
    Letinier, L.
    Ferreira, A.
    Pageot, C.
    Babin, M.
    Micallef, J.
    Miremont, G.
    Pariente, A.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2019, 33 : 32 - 32
  • [24] Core Drug-Drug Interaction Alerts for Inclusion in Pediatric Electronic Health Records With Computerized Prescriber Order Entry
    Harper, Marvin B.
    Longhurst, Christopher A.
    McGuire, Troy L.
    Tarrago, Rod
    Desai, Bimal R.
    Patterson, Al
    JOURNAL OF PATIENT SAFETY, 2014, 10 (01) : 59 - 63
  • [25] Are We Heeding the Warning Signs? Examining Providers' Overrides of Computerized Drug-Drug Interaction Alerts in Primary Care
    Slight, Sarah P.
    Seger, Diane L.
    Nanji, Karen C.
    Cho, Insook
    Maniam, Nivethietha
    Dykes, Patricia C.
    Bates, David W.
    PLOS ONE, 2013, 8 (12):
  • [26] Reducing the risk of drug-drug interactions: A goal of rational drug development
    Preskorn, SH
    JOURNAL OF CLINICAL PSYCHIATRY, 1996, 57 : 3 - 6
  • [27] Pharmacological Management of Cancer Patients: Focus on Drug-Drug Interactions
    Rashid, Anis
    Shah, Asim
    Scheurmeyer, Isabel
    Walker, Paul
    PSYCHO-ONCOLOGY, 2014, 23 : 43 - 43
  • [28] Antidepressant drug-drug interactions: Clinical relevance and risk management
    Nemeroff, Charles B.
    Preskorn, Sheldon H.
    DeVane, C. Lindsay
    CNS SPECTRUMS, 2007, 12 (05) : 4 - +
  • [29] Drug-Drug Interactions in the Management of Patients With Pulmonary Arterial Hypertension
    Wu, Sheryl
    Hoang, Heather B.
    Yang, Jenny Z.
    Papamatheakis, Demosthenes G.
    Poch, David S.
    Alotaibi, Mona
    Lombardi, Sandra
    Rodriguez, Cynthia
    Kim, Nick H.
    Fernandes, Timothy M.
    CHEST, 2022, 162 (06) : 1360 - 1372
  • [30] COCAINE DRUG-DRUG INTERACTIONS
    ROSEN, EH
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 1992, 12 (06) : 445 - 445